BioJoe Bress is a Principal at The Carlyle Group focused on private equity opportunities in the healthcare sector. He is based in New York.Since joining Carlyle in 2007, Mr. Bress has been involved in investing/managing over $4 billion of equity investments into health care companies globally. He currently sits on the Board of Directors of WellDyneRx, Albany Molecular Research, and Visionary RCM. He is also involved in ....
Work Experience
Current
Past